AMAT Stock News Applied Materials (AMAT) 21.19 07/30/2014 00

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Applied Materials (AMAT) 21.19 $AMAT

Most active Nasdaq-traded stocks
AP - Tue Jul 29, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Applied Materials (AMAT) Breaks Through Support at $20.90
Comtex SmarTrend(R) - Mon Jul 28, 9:27AM CDT
Applied Materials (NASDAQ:AMAT) has opened bearishly below the pivot of $21.27 today and has reached the first level of support at $20.90. Investors may be interested in a cross of the next downside pivot targets of $20.57 and $19.87.

3 Huge Stocks on Traders' Radars
at The Street - Mon Jul 28, 8:23AM CDT
Here's how to trade some of the most active stocks on the market today.

KLA-Tencor Q4 Earnings, Q1 Outlook Miss; Stock Slides
at Investor's Business Daily - Fri Jul 25, 1:45PM CDT
KLA-Tencor (KLAC) stock, which this month hit 14-year highs, fell as much as 4% Friday after the chip-equipment maker's shares fiscal Q4 earnings late Thursday missed Wall Street and its own expectations. KLA-Tencor stock, though, recovered somewhat...

Chip Manufacturing Equipment Demand Sees Order Uptick
at Investor's Business Daily - Fri Jul 25, 12:55PM CDT
The latest report from the chip-equipment manufacturing industry is a positive for industry leaders such as Applied Materials (AMAT). U.S. manufacturers of chip equipment booked $1.47 billion in new orders in June, while they billed $1.34 billion for...

KLA-Tencor Falls: Q4 Earnings, Q1 Outlook Miss Estimates - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Fri Jul 25, 12:01PM CDT
KLAC reported fourth-quarter 2014 earnings that missed our expectations and provided very weak guidance citing longer-lead time business.

Semiconductor Equipment Stocks Review -- Amkor Technology, Applied Materials, Teradyne, ASML Holding, and Lam Research
PR Newswire - Wed Jul 23, 7:50AM CDT
On Tuesday, July 22, 2014, the NASDAQ Composite ended at 4,456.02, up 0.71%, the Dow Jones Industrial Average advanced 0.36%, to finish the day at 17,113.54, and the S&P 500 closed at 1,983.53, up 0.50%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Information Technology Sector Index ended the day at 655.16, up 0.86%, with the index also advancing 10.45% in the previous three months. Investor-Edge has initiated coverage on the following equities: Amkor Technology Inc. (NASDAQ: AMKR), Applied Materials Inc. (NASDAQ: AMAT), Teradyne Inc. (NYSE: TER), ASML Holding N.V. (NASDAQ: ASML), and Lam Research Corporation (NASDAQ: LRCX). Free research on these five companies can be accessed at:

A*STAR and Industry Form S$200M Semiconductor R&D Joint Labs
PR Newswire - Wed Jul 23, 1:59AM CDT
Public-Private Partnership to drive innovative solutions for complex micro chip manufacturing

Applied Materials Falls 1.70% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 22, 3:55PM CDT
Applied Materials (NASDAQ:AMAT) traded in a range yesterday that spanned from a low of $22.32 to a high of $22.91. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $22.66 on volume of 24.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.70%, Applied Materials Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 22, 3:54PM CDT
Applied Materials (NASDAQ:AMAT) traded in a range yesterday that spanned from a low of $22.32 to a high of $22.91. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $22.66 on volume of 24.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Why Applied Materials (AMAT) Stock Is Falling Today
at The Street - Tue Jul 22, 1:34PM CDT
Applied Materials (AMAT) is falling Tuesday following a report that Chinese authorities are opposing the company's merger with Tokyo Electron (TOELY).

Watch for Shares of Applied Materials (AMAT) to Approach Support at $22.63
Comtex SmarTrend(R) - Tue Jul 22, 12:27PM CDT
Applied Materials (NASDAQ:AMAT) has opened bearishly below the pivot of $22.98 today and has reached the first level of support at $22.77. Investors may be interested in a cross of the next downside pivot targets of $22.63 and $22.28.

Williams: Shorting Tesla's Batteries
at The Street - Tue Jul 22, 9:24AM CDT
The upside seems limited; the downside seems limitless.

ASML Stock Tumbles After Full-Year Guidance Cut
at Investor's Business Daily - Thu Jul 17, 1:08PM CDT
ASML Holdings (ASML) was down 2.5% in the stock market today after the Dutch maker of lithography gear for the chip industry lowered its full-year guidance, though its Q2 earnings beat expectations. Late Wednesday, ASML reported Q2 earnings of $1.25...

Applied Materials Has Returned 12.3% Since SmarTrend Recommendation (AMAT)
Comtex SmarTrend(R) - Thu Jul 17, 9:29AM CDT
SmarTrend identified an Uptrend for Applied Materials (NASDAQ:AMAT) on May 27th, 2014 at $20.27. In approximately 2 months, Applied Materials has returned 12.34% as of today's recent price of $22.76.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading